{"id":"559081-2706","orgnr":"559081-2706","name":"Neoki Pharma AB","name_registered_on":"2016-11-29","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2016-10-20","business_description":"Bolaget ska bedriva konsultverksamhet inom läkemedelsutveckling samt därmed förenlig verksamhet.","industries":[{"code":"72109","name":"Annan naturvetenskaplig och teknisk forskning och utveckling"}],"postal_address":{"city":"UPPSALA","country":"SE","municipality":{"code":"0380","name":"Uppsala"},"county":{"code":"03","name":"Uppsala län"}},"registered_office":{"municipality":{"code":"0380","name":"Uppsala"},"county":{"code":"03","name":"Uppsala län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"0","name":"< 1 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"deregistered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"K2","signed_on":"2026-06-29","documents":{"annual_report":"/v1/documents/ccf82b6b-a561-4eb6-a58c-2bb91b785613.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/27_12.zip"}},{"from":"2024-01-01","to":"2024-12-31","framework":"K2","signed_on":"2025-06-02","documents":{"annual_report":"/v1/documents/95a566d1-ef48-4e52-937b-b3b8b3db40f4.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/25_5.zip"}},{"from":"2023-01-01","to":"2023-12-31","framework":"K2","signed_on":"2024-02-29","documents":{"annual_report":"/v1/documents/b1924421-818a-4883-8a0f-e207bfdab0c1.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/09_3.zip"}},{"from":"2022-01-01","to":"2022-12-31","framework":"K2","signed_on":"2023-05-22","documents":{"annual_report":"/v1/documents/777d3d63-b9f5-4944-a02b-0f812e4e4ada.xhtml"},"source":{"dataset":"arsredovisningar","file":"2023/26_8.zip"}},{"from":"2021-01-01","to":"2021-12-31","framework":"K2","signed_on":"2022-06-29","documents":{"annual_report":"/v1/documents/f1de5034-e50f-49b3-b784-4692f84b339c.xhtml"},"source":{"dataset":"arsredovisningar","file":"2022/26_5.zip"}},{"from":"2020-01-01","to":"2020-12-31","framework":"K2","signed_on":"2021-04-14","documents":{"annual_report":"/v1/documents/3463da15-41f8-4695-bc9c-b251cfe2c29b.xhtml"},"source":{"dataset":"arsredovisningar","file":"2021/15_2.zip"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"company","currency":"SEK","net_sales":-1,"operating_profit":-35846,"profit_after_financial_items":-36586,"net_profit":1150,"total_assets":1867482,"current_assets":417482,"equity":1674521,"share_capital":50000,"unrestricted_equity":1624521,"untaxed_reserves":240600,"long_term_liabilities":7568,"current_liabilities":-55207,"tax_liabilities":-55207,"cash":387808,"staff_costs":0,"equity_ratio":0.999,"net_sales_growth":-1,"source":{"annual_report":"2025-12-31","document":"/v1/documents/ccf82b6b-a561-4eb6-a58c-2bb91b785613.xhtml"},"anchors":{"cash":{"text":"387 808","prefix":"Summa kassa och bank","suffix":"615 758"},"current_assets":{"text":"417 482"},"current_liabilities":{"text":"55 207","suffix":"189"},"equity":{"text":"1 674 521","prefix":"kapital"},"equity_ratio":{"text":"99,9"},"long_term_liabilities":{"text":"7 568","prefix":"långfristiga skulder"},"net_profit":{"text":"1 150","suffix":"228"},"net_sales":{"text":"1","suffix":"414"},"operating_profit":{"text":"35 846"},"profit_after_financial_items":{"text":"36 586"},"share_capital":{"text":"50 000","prefix":"utgång"},"staff_costs":{"text":"0","prefix":"2"},"tax_liabilities":{"text":"55 207","suffix":"54"},"total_assets":{"text":"1 867 482","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"1 624 521","prefix":"150"},"untaxed_reserves":{"text":"240 600","prefix":"reserver"}}},"officers":{"annual_report":"2025-12-31","signed_on":"2026-06-29","signatories":[{"name":"T*****"}]}}